Related Experiment Videos
Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations
P Hadaczek1, J Podolski, A Toloczko
1Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland.
Abstract:
Deletions of the short arm of chromosome 3 (3p) have been recognized as characteristic features of clear cell renal cell carcinomas (clear cell RCC). We analysed 55 clear-cell RCCs and 30 non-clear-cell kidney tumours (10 papillary and 7 chromophobic RCCs, 11 oncocytomas and 2 collecting duct carcinomas) in loss of heterozygosity (LOH) studies using microsatellite markers for previously observed regions of common deletions on 3p in kidney tumours (3p25, 3p21.3, 3p14.2 and 3p12-13). Alterations were found in all 55 cases of clear-cell RCCs at two to four of the 3p regions. Extensive losses were not found in non-clear-cell tumours except for collecting duct carcinomas; 1 of 10 papillary RCCs showed interstitial deletion limited to a single 3p21.3 locus. LOH analyses using microsatellite markers for regions of common deletions at 3p may be of value in differential diagnosis of kidney tumours.
Insights
Loss of genetic material on chromosome 3p is a hallmark of clear cell renal cell carcinoma (ccRCC). Analyzing these deletions using loss of heterozygosity (LOH) studies can aid in distinguishing ccRCC from other kidney tumors.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Deletions of the short arm of chromosome 3 (3p) are characteristic of clear cell renal cell carcinomas (ccRCC).
- Understanding the genetic alterations in kidney tumors is crucial for accurate diagnosis and treatment.
- Loss of heterozygosity (LOH) studies are valuable tools for detecting chromosomal deletions.
Purpose of the Study:
- To investigate the frequency and patterns of 3p deletions in clear cell RCC and other kidney tumor types.
- To assess the utility of LOH analysis for the differential diagnosis of kidney tumors.
- To identify specific 3p regions frequently altered in ccRCC.
Main Methods:
- Analysis of 55 clear cell RCCs and 30 non-clear cell kidney tumors (papillary RCC, chromophobic RCC, oncocytomas, collecting duct carcinomas).
- Loss of heterozygosity (LOH) studies using microsatellite markers.
- Targeted analysis of previously identified common deletion regions on 3p (3p25, 3p21.3, 3p14.2, 3p12-13).
Main Results:
- All 55 clear cell RCC cases exhibited alterations in two to four of the analyzed 3p regions.
- Non-clear cell tumors generally did not show extensive 3p losses, with one exception of papillary RCC with a single locus deletion.
- Collecting duct carcinomas also showed extensive losses, indicating a different genetic profile.
- LOH analysis revealed specific patterns of 3p deletions in ccRCC.
Conclusions:
- Loss of heterozygosity analysis of 3p regions is highly sensitive for detecting clear cell RCC.
- These genetic alterations can serve as a valuable biomarker for differentiating clear cell RCC from other renal neoplasms.
- Further research into specific 3p deletion patterns may refine diagnostic and prognostic capabilities for kidney tumors.